
- /
- Supported exchanges
- / US
- / RMCO.NASDAQ
Royalty Management Holding Corporation (RMCO NASDAQ) stock market data APIs
Royalty Management Holding Corporation Financial Data Overview
Royalty Management Holding Corporation, a royalty company, acquires and develops assets in various markets. Its portfolio includes intellectual property, natural resources assets, patents, and emerging technologies. The company was founded in 2021 and is based in Fishers, Indiana.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Royalty Management Holding Corporation data using free add-ons & libraries
Get Royalty Management Holding Corporation Fundamental Data
Royalty Management Holding Corporation Fundamental data includes:
- Net Revenue: 1 568 K
- EBITDA: -378 934
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-14
- EPS/Forecast: NaN
Get Royalty Management Holding Corporation End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Royalty Management Holding Corporation News

Royalty Management Holding Corporation Regains Full Compliance with Nasdaq Listing Standards
In Response to a January 2025 Letter From the Nasdaq, Company Completes Annual Shareholder Meeting, Which was Final Step to Regain Compliance With Its Listing Standards FISHERS, INDIANA - June 26, 20...


11 Best Asset Management Stocks to Buy Now
In this piece, we will take a look at the 11 best asset management stocks to buy now. If you want to skip our overview of financial markets, then you can take a look at the 5 Best Asset Management Sto...

Market Today: CRISPR Therapeutics and Vertex Pharmaceuticals Make History with UK Drug Approval
The gene editing sector experienced a significant shakeup as CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharmaceuticals (NASDAQ:VRTX) received UK approval for their groundbreaking CRISPR-based drug ...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.